-transparent.png){kind=logo}
We have constructed a series of MLV-based retroviral vectors and packaging components expressed from the CMV promoter and carried on plasmids containing SV40 origins of replication. These two features greatly enhanced retroviral gene expression when introduced into cell lines carrying the SV40 large T antigen. The two packaging components, gag-pol and env, were placed on separate plasmids to reduce helper virus formation. Using a highly transfectable human cell line and sodium butyrate to further increase expression of each component, we achieved helper-free viral stocks of approximately 10(7) infectious units/ml by 48 h after transient co-transfection with the three plasmid components. This system can be used both for the generation of high titer retroviral stocks for transduction and for the rapid screening of a large number of MLV gag-pol or env mutants.
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
August 2007,
Acta biochimica et biophysica Sinica,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
January 2001,
Biotechnology progress,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
February 1998,
Molecules and cells,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
April 2006,
Journal of bioscience and bioengineering,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
August 2000,
Molecular therapy : the journal of the American Society of Gene Therapy,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
February 2004,
Journal of virology,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
May 2001,
Current protocols in molecular biology,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
January 1997,
Methods in molecular medicine,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
December 2007,
Gene therapy,
Y Soneoka, and
P M Cannon, and
E E Ramsdale, and
J C Griffiths, and
G Romano, and
S M Kingsman, and
A J Kingsman
January 1990,
Annals of the New York Academy of Sciences,
